Anti-MMP2 antibody [4D3]
4
(3 Reviews)
|
(36 Publications)
Mouse Monoclonal MMP2 antibody. Suitable for WB and reacts with Human samples. Cited in 36 publications. Immunogen corresponding to Synthetic Peptide within Human MMP2 aa 550-600.
View Alternative Names
CLG4A, MMP2, 72 kDa type IV collagenase, 72 kDa gelatinase, Gelatinase A, Matrix metalloproteinase-2, TBE-1, MMP-2
- WB
Supplier Data
Western blot - Anti-MMP2 antibody [4D3] (AB2462)
400 ng samples of recombinant human pro-enzyme (lane 1 = MMP-1; lane 2 = MMP-3; lane 3 = MMP-2; lane 4 = MMP-9) were subjected to SDS-PAGE, transferred to PVDF membrane, and detected by immunoblotting with ab2462 specific for MMP-2.
All lanes:
Western blot - Anti-MMP2 antibody [4D3] (ab2462)
Predicted band size: 73 kDa
false
Reactivity data
Properties and storage information
Form
Purity
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Matrix metalloproteinase-2 is mainly involved in the degradation of type IV and V collagens gelatin and fibronectin. As part of the metalloproteinase family it works alongside other MMPs to maintain tissue homeostasis and repair. MMP-2 forms part of a complex network that ensures the timely degradation of matrix components balancing synthesis and breakdown. It remains regulated by tissue inhibitors of metalloproteinases (TIMPs) preventing excessive degradation that could lead to tissue damage.
Pathways
MMP-2 plays a significant role within the extracellular matrix (ECM) remodeling and angiogenesis pathways. It interacts with various proteins including integrins and TIMP-2 to modulate cellular behaviors such as migration and invasion. MMP-2 contributes to processes like wound healing and embryonic development through its involvement in ECM degradation and new tissue formation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (36)
Recent publications for all applications. Explore the full list and refine your search
International journal of ophthalmology 15:914-923 PubMed35814898
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cells, tissues, organs 212:185-193 PubMed34781297
2021
Applications
Unspecified application
Species
Unspecified reactive species
CNS neuroscience & therapeutics 28:64-76 PubMed34729926
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:1301 PubMed34630656
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunology research 2021:5569354 PubMed33869638
2021
Applications
Unspecified application
Species
Unspecified reactive species
Archives of gynecology and obstetrics 303:1075-1087 PubMed33128584
2020
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 13:10465-10473 PubMed33116626
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Nucleic acids 22:114-123 PubMed32916597
2020
Applications
Unspecified application
Species
Unspecified reactive species
Ophthalmic research 64:99-107 PubMed32564013
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 11:1584-1595 PubMed32047564
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com